FEDRATINIB

Fedratinib 100 mg capsule, 120

FEDRATINIB (15279E)

Fedratinib 100 mg capsule, 120
15279E
Body System:
Manner of administration:Oral
General Schedule
Authority Required (STREAMLINED)

Restriction  18324

Indication: High risk and intermediate-2 risk myelofibrosis
Treatment phase: Continuing treatment

Restriction  18241

Indication: Intermediate-1 risk myelofibrosis
Treatment phase: Continuing treatment
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 1 Max qty units: 120 # of repeats: 5 DPMQ: $5,800.71 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
Inrebic